pharma · Test of vasocontriction properties for classification of topical steroid potency
Cassopeia Pharmaceuticals Pvt
Cassiopea S.p.A.
Cassiopea S.p.A is a pharma organization headquartered in LAINATE, IT. Primary therapeutic focus areas include Test of vasocontriction properties for classification of topical steroid potency. NovaPharmaNews links 1 clin
Company details
- Status
- Public
- HQ
- Chandigarh, IN
- Founded
- 2020
- Employees
- 4
- Programs
- 1
- Drugs
- 6
- Patents
- 12
CB-03-01/39
Phase 1 · other · Test of vasocontriction properties for classification of topical steroid potency
CB-03-01/39 for Test of vasocontriction properties for classification of topical steroid potency is a Phase 1 program (other) at Cassiopea S.p.A. with 1 ClinicalTrials.gov record(s).
Internal code CB-03-01/39
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Cassiopea S.p.A.
- Phase
- Phase 1
- Modality
- other
- Indication
- Test of vasocontriction properties for classification of topical steroid potency
- Status
- active
- Trials
- 1